FDA classifies digital cervical cytology slide imaging systems that use AI algorithms
According to a Federal Register notice, the FDA has established a classification for digital cervical cytology slide imaging systems that use an AI algorithm. The decision, covering hematology and pathology devices, provides a framework for authorising such products.
Who is affected and how
- medtech company
- The classification determines the regulatory pathway and the evidence required to bring cytology AI tools to market.
- doctor
- For pathologists and cytologists, regulated use of AI-assisted screening reads moves closer.
Sources
- Federal Register :: Medical Devices; Hematology and Pathology Devices; Classification of the Digital Cervical Cytology Slide Imaging System With Artificial Intelligence Algorithmfederalregister.gov · Nov 4, 2026
- 5 Ways Artificial Intelligence Is Reshaping Digital Diagnosticsdimensionspoint.com · Nov 5, 2026 · magyar
- Medical Devices; Hematology and Pathology Devices; Classification of the Digital Cervical Cytology Slide Imaging System With Artificial Intelligence Algorithm | GovSourcegovsrc.com · Nov 5, 2026
- 5 Ways Digital Pathology Is Transforming Healthcarepuckermob.com · Nov 5, 2026
Machine-generated summary based on the titles and excerpts of the source articles. The source article is the authority for the facts. News monitoring, not medical advice: consult a doctor for health decisions.